BioVie Inc Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Development Clearwater Paper Q1 2026 Earnings Loss Narrows on Positive Surprise Stock Edges Lower IDT Q1 2026 Earnings EPS Falls Short Amid Challenging Environment BBUC Q1 2026 Earnings Profitability Shines in a Quiet Quarter Canopy Growth CGC Q1 2026 Earnings Deep EPS Miss Casts Shadow Over Cannabis Sector C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution